Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 5,126 Cr.
- Current Price ₹ 185
- High / Low ₹ 326 / 160
- Stock P/E 42.5
- Book Value ₹ 69.0
- Dividend Yield 0.27 %
- ROCE 8.77 %
- ROE 6.16 %
- Face Value ₹ 2.00
Pros
- Company's working capital requirements have reduced from 20.9 days to 11.2 days
Cons
- Stock is trading at 2.68 times its book value
- Company has a low return on equity of 7.72% over last 3 years.
- Dividend payout has been low at 11.5% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.16%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
902 | 1,008 | 1,273 | 1,429 | 1,359 | 1,606 | 2,877 | 2,691 | 2,824 | 2,945 | 2,898 | |
825 | 892 | 1,124 | 1,275 | 1,239 | 1,401 | 2,541 | 2,444 | 2,566 | 2,655 | 2,656 | |
Operating Profit | 76 | 116 | 149 | 154 | 120 | 205 | 337 | 247 | 258 | 289 | 242 |
OPM % | 8% | 12% | 12% | 11% | 9% | 13% | 12% | 9% | 9% | 10% | 8% |
3 | 2 | 4 | 6 | 33 | 9 | 21 | 29 | 29 | 19 | 27 | |
Interest | 18 | 11 | 10 | 16 | 15 | 18 | 17 | 22 | 6 | 20 | 17 |
Depreciation | 28 | 27 | 29 | 41 | 48 | 45 | 47 | 70 | 105 | 122 | 109 |
Profit before tax | 32 | 81 | 113 | 103 | 90 | 151 | 294 | 183 | 176 | 166 | 142 |
Tax % | 23% | 12% | 32% | 24% | 13% | 19% | 18% | 27% | 28% | 29% | |
25 | 71 | 77 | 78 | 79 | 123 | 240 | 135 | 127 | 118 | 121 | |
EPS in Rs | 24.56 | 70.71 | 76.66 | 15.54 | 17.46 | 4.65 | 9.09 | 5.08 | 4.62 | 4.26 | 4.36 |
Dividend Payout % | 4% | 0% | 0% | 2% | 10% | 11% | 8% | 10% | 13% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 1% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | -22% |
TTM: | -23% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -16% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 8% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 |
Reserves | 224 | 294 | 370 | 405 | 396 | 992 | 1,230 | 1,367 | 1,745 | 1,857 |
199 | 79 | 194 | 143 | 138 | 75 | 99 | 372 | 139 | 255 | |
158 | 227 | 258 | 359 | 445 | 616 | 785 | 537 | 880 | 874 | |
Total Liabilities | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,820 | 3,040 |
207 | 195 | 273 | 327 | 327 | 315 | 361 | 694 | 872 | 1,161 | |
CWIP | 33 | 48 | 30 | 31 | 23 | 60 | 177 | 88 | 459 | 419 |
Investments | 19 | 23 | 20 | 20 | 21 | 25 | 32 | 287 | 149 | 167 |
332 | 344 | 509 | 579 | 653 | 1,335 | 1,597 | 1,259 | 1,341 | 1,294 | |
Total Assets | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,820 | 3,040 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
135 | 110 | 61 | 161 | 521 | 114 | |||||
-3 | -604 | 44 | -362 | -494 | -274 | |||||
-115 | 485 | -87 | 241 | -10 | 91 | |||||
Net Cash Flow | 17 | -9 | 17 | 40 | 16 | -68 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 61 | 78 | 83 | 78 | 85 | 87 | 79 | 73 | 78 | 67 |
Inventory Days | 61 | 34 | 51 | 48 | 57 | 59 | 60 | 50 | 48 | 68 |
Days Payable | 70 | 85 | 83 | 112 | 154 | 155 | 127 | 93 | 146 | 133 |
Cash Conversion Cycle | 52 | 27 | 51 | 13 | -12 | -8 | 12 | 30 | -20 | 3 |
Working Capital Days | 12 | 16 | 25 | 27 | 34 | 5 | 42 | 33 | 18 | 11 |
ROCE % | 22% | 26% | 20% | 14% | 20% | 25% | 13% | 9% | 9% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
1d - Laxmi Organic Industries Limited has informed about the allotment of Shares under ESOP - 2020 Scheme.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - The officials of the Company will be meeting Analysts/ Investors (Participants) scheduled on August 14, 2025 at 10:00 AM to 02:00 PM (IST)
-
Intimation of Repayment of Commercial Paper (CP)
1d - Laxmi Organic repaid ₹50 Cr commercial paper matured on August 7, 2025.
-
Intimation of Repayment of Commercial Paper (CP)
1d - Laxmi Organic paid ₹50 Cr commercial paper redemption on August 7, 2025 as scheduled.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
1d - No deviation in QIP proceeds utilization; monitoring report for June 2025 quarter enclosed.
Annual reports
Concalls
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
May 2025TranscriptNotesPPT
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021Transcript PPT
Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.